Xencor Inc
Change company Symbol lookup
Select an option...
XNCR Xencor Inc
ALT Altimmune Inc
RZLT Rezolute Inc
BNKU MicroSectors? U.S. Big Banks Index 3X Leveraged ETNs
SGFY Signify Health Inc
FRC First Republic Bank
BACK IMAC Holdings Inc
LYLT Loyalty Ventures Inc
BOXD Boxed Inc
ALLR Allarity Therapeutics Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company is advancing a portfolio of clinical-stage XmAb drug candidates from its protein engineering technology platforms. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design technologies and XmAb development candidates with properties. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Tidutamab, XmAb841, XmAb306, AMG 509, XmAb819, XmAb104, XmAb564 and Novartis XmAb.

Price
Delayed
$28.96
Day's Change
0.23 (0.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
29.00
Day's Low
28.46
Volume
(Light)

Today's volume of 14,755 shares is on pace to be much lighter than XNCR's 10-day average volume of 505,883 shares.

14,755

Enterprise Financial Services Corp Announces Fourth Quarter 2022 Earnings Release and Conference Call

6:30 pm ET January 6, 2023 (BusinessWire) Print

Enterprise Financial Services Corp (Nasdaq: EFSC) ("the Company" or "EFSC") will release its fourth quarter 2022 financial results on Monday, January 23, 2023. The Company will host a conference call and webcast at 10:00 a.m. CT on Tuesday, January 24, 2023. The conference call will be accessible by telephone at 1-888-550-5279 (Conference ID #7004515). The webcast will be accessible via the "Investor Relations" page of the Company's website, www.enterprisebank.com. The press release and related presentation slides will be accessible via the same website page prior to the scheduled call. A recorded replay of the conference call will be available on the website beginning two hours after the call's completion. To access the audio replay, please visit https://bit.ly/EFSC4Q2022. The replay will be available for approximately two weeks following the conference call.

Enterprise Financial Services Corp (Nasdaq: EFSC), with approximately $13.0 billion in assets, is a financial holding company headquartered in Clayton, Missouri. Enterprise Bank & Trust, a Missouri state-chartered trust company with banking powers and a wholly-owned subsidiary of EFSC, operates branch offices in Arizona, California, Kansas, Missouri, Nevada, and New Mexico; and SBA loan and deposit production offices throughout the country. Enterprise Bank & Trust offers a range of business and personal banking services, and wealth management services. Enterprise Trust, a division of Enterprise Bank & Trust, provides financial planning, estate planning, investment management, and trust services to businesses, individuals, institutions, retirement plans and non-profit organizations. Additional information is available at www.enterprisebank.com.

Enterprise Financial Services Corp's common stock is traded on the Nasdaq Stock Market under the symbol "EFSC." Please visit our website at www.enterprisebank.com to see our regularly posted material information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230106005458/en/

SOURCE: Enterprise Financial Services Corp

For Investor Relations Contact:
Keene Turner, Executive Vice President and CFO (314) 512-7233
For Media Inquiries Contact:
Steve Richardson, Senior Vice President, Corporate Communication (314) 995-5695
comtex tracking

COMTEX_422239234/1006/2023-01-06T18:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.